Pfizer (PFE) stock gains as lung cancer therapy, Lorbrena, shows promising results in reducing disease progression or death ...
A 12-year-old boy in the Washington, D.C., area faces months of procedures to remedy his disease. “I want to be cured,” he said. By Gina Kolata Photographs by Kenny Holston Gina Kolata visited ...
Pfizer is among companies working in recent years to develop DMD gene therapies. The first DMD gene therapy reached the market after Sarepta Therapeutics won FDA accelerated approval in June 2023 ...
the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis; and the treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement ...
This health news summary spotlights major developments in cancer treatments, regulatory actions on biotechnology, and the ...
Kendric Cromer is the first commercial patient to receive the groundbreaking treatment. Kendric Cromer, 12, is the first patient in the United States to undergo a newly approved gene therapy for ...
The global cell and gene therapy market is experiencing significant growth, driven by technological advancements, increasing ...
A young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy trial has died, the pharma shared in a May 7 letter (PDF) cited by nonprofit Parent Project ...
This summary covers recent health news highlights, including Gilead's Trodelvy failing in a bladder cancer trial, Pfizer's ...
Since the recombinant viral genomes are devoid of any viral genes (which are also not expressed by the infected target cell), the recombinant viral vectors can only infect a cell and are ...
Stimulants are typically the go-to option for doctors prescribing treatments for attention-deficit hyperactivity disorder (ADHD). But some ADHD patients do not respond adequately to stimulants or ...
When we think of smoking-related cancers, lung cancer usually comes to mind. But smoking is also a major driver for bladder cancer. Now, a new treatment has come to Philadelphia to help more ...